Columbia Laboratories announces the acquisition of a new natural bioadhesive technology.MIAMI--(BUSINESS WIRE)--July 6, 1995--Columbia Laboratories, Inc. (AMEX:COB) today announced it has acquired worldwide rights to a newly developed, protein based, bioadhesive technology for all applications in women's health care. The inventor, Professor Jean-Marc Alche of th Faculte de Pharmacie, at the University of Clermont-Ferrand Clermont-Ferrand (klĕrmôN`-fĕräN`), city (1990 pop. 140,167), capital of Puy-de-Dôme dept., central France, in Auvergne, on the Tiretaine River. One of the population and industrial centers of the Massif Central, it is home of the Michelin and other tire factories, and of important metallurgical works., France, a world authority on bioadhesive delivery systems, has applied this new technology to buccal buc·cal (b  k  l)adj. , vaginal, nasal and rectally delivered products. 1. Of, relating to, adjacent to, or in the direction of the cheek. This natural protein based bioadhesive technology is a complement to Columbia's original patented bioadhesive delivery system and enhances the company's ability to further expand its portfolio of unique products in women's health care. When drugs and hormones are given orally, they are often inactivated after ingestion 1. The act of taking food and drink into the body by the mouth. 2. The taking in of particles by a phagocytic cell. in·gest (-j by the liver; this is known as the first liver pass effect. This new technology facilitates the process of developing buccal patches that can be used to avoid first pass inactivation by the liver. Early clinical trials have demonstrated that buccal patches developed with this newly acquired technology can deliver drugs through the buccal cavity buccal cavityn. for up to 24 hours. The portion of the oral cavity bounded by the lips, cheeks, and gums. Also called vestibule of mouth. "This new bioadhesive delivery system expands our range in women's health care product development by making it possible to deliver hormones from buccal patches that are smaller than a contact lens," said William J. Bologna, Chairman of the Board. Columbia Laboratories, Inc. is a U.S.-based international pharmaceutical company, dedicated to the development of women's prescription and over-the-counter products, including those which help prevent sexually transmitted diseases. Columbia's products primarily utilize the Company's patented bioadhesive delivery technology. CONTACT: Columbia Laboratories, Inc. Margaret J. Roell, 305/860-1692 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion